Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
S$0.78 B
Marketcap
S$22.42
Share price
-0.91%
Change (1 day)
-47.68%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): S$0.65

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is S$0.65. In 2025 the company made an earnings per share (EPS) of S$0.95 an increase over its 2024 EPS that were of S$0.78.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$0.65-32.13%
2025S$0.9521.69%
2024S$0.7821.02%
2023S$0.65